Additionally, interactions between the SARS-CoV-2 spike protein and the expression of the angiotensin-converting enzyme 2 (ACE2) receptor on the digestive tract might also be involved in the progression of digestive diseases among COVID-19 patients. This evidence concerns the gene ACE2 and digestive system disorder.